The Burden of Musculoskeletal Pain

Musculoskeletal conditions account for:

• High outpatient visit volume
• Significant lost productivity
• Recurrent imaging and procedural costs
• Long-term medication reliance
  

In many communities, particularly underserved areas, access to specialty care is limited. Physical therapy appointments may be weeks away. Orthopedic consultations may require travel.
When conservative care is inaccessible, patients often default to medication.
Expanding access means broadening the foundation of care.

Drug-Free Modalities in Population Health

Non-drug, wearable therapies offer several characteristics that align with population health goals:

• Over-the-counter accessibility
• Minimal systemic risk
• Ease of distribution
• Self-directed application
• Compatibility with telehealth oversight
  

Because they do not require in-office administration, these therapies can extend musculoskeletal support beyond clinic walls.
This becomes particularly relevant in decentralized care models.

CMS and Broader Access Initiatives

Healthcare systems are increasingly focused on value-based models — reducing long-term costs while improving functional outcomes.
Programs designed to expand care access often emphasize:

• Preventive intervention
• Reduced emergency department utilization
• Lower medication dependence
• Remote monitoring and oversight
• Scalable, cost-effective solutions
  

Wearable, drug-free pain therapy aligns with these goals.When therapy can be delivered continuously, locally, and without systemic exposure, it supports earlier intervention in the pain trajectory.
Earlier intervention may reduce downstream escalation — including advanced imaging, procedural intervention, and long-term medication use.

Infrastructure, Not Just Devices

Access initiatives succeed when devices are integrated into structured systems
That means pairing therapy with:

• Education
• Telehealth intake
• Periodic clinical oversight
• Progress tracking
• Escalation pathways when appropriate
  

A standalone device is a product.
A structured platform is infrastructure.
Public health adoption depends on infrastructure.

Equity and Practical Deployment

In rural and underserved populations, several barriers exist:

• Limited specialty access
• Transportation challenges
• Insurance complexity
• Delayed follow-up
  

Non-drug, over-the-counter therapies can reduce friction at the first step of care.
When paired with remote clinical guidance, they create a hybrid model: accessible yet accountable.
This hybrid structure aligns with broader goals of decentralizing musculoskeletal care while maintaining clinical oversight.

Reducing the Long-Term Cost Curve

Chronic back pain and osteoarthritis drive cumulative costs over years.
Even modest reductions in:

• Daily NSAID use
• Repeat urgent visits
• Imaging frequency
• Procedural escalatio
  

can have meaningful economic impact at scale.
Drug-free wearable therapy is not a singular solution to healthcare cost inflation. But as part of a layered strategy, it may contribute to more sustainable musculoskeletal management.

A Scalable Foundation

Public health initiatives often struggle when solutions require:
High capital equipment
Complex training
Intensive facility requirements
Repeated in-person visits
Wearable, low-energy bioelectric therapy avoids many of those barriers.
It can be distributed widely. It requires minimal user training. It does not rely on centralized infrastructure.
That scalability is critical in any access-focused initiative.

The Next Phase of Pain Care

Healthcare systems are increasingly asking:
How do we provide early, structured, drug-sparing support for chronic pain?
How do we reduce escalation before it becomes entrenched?
How do we deliver care beyond traditional clinic walls?
Non-drug, wearable therapy does not replace physicians, therapists, or structured programs.
It expands the toolkit.
In the next article, we focus specifically on rural populations — examining how access challenges uniquely affect musculoskeletal care and how decentralized therapy models may help bridge those gaps.